With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for ...

Updated interim ACR-368 clinical data from the ongoing registrational-intent Phase 2b study as well as an update on the additional recently initiated tumor biopsy-independent Phase 2b arm, and the ...

WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- . (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utiliz ...

Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer in at-risk patients.

Proteomics International says its PromarkerD diabetes test reshapes medical decision-making, with high scores prompting an increase in kidney-protecting therapies.

Multi-omics analysis has emerged as a powerful approach in translational medicine, integrating diverse molecular data to ...

The global Proteomics Market is on a rapid growth trajectory, projected to reach USD 134.82 billion by 2035 from an estimated USD 44.79 billion in 2025, reflecting a robust CAGR of 11.7%. Driven by ...

Julio Aguirre-Ghiso, PhD, Rose C. Falkenstein Chair in Cancer Research, Professor of Cell Biology and Founding Director of the Cancer Dormancy Institute at Albert Einstein's Montefiore Einstein ...

n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...